Reuters logo
6 months ago
BRIEF-Zealand Pharma says patient recruitment completed for Phase II trial with glepaglutide
February 6, 2017 / 2:36 PM / 6 months ago

BRIEF-Zealand Pharma says patient recruitment completed for Phase II trial with glepaglutide

1 Min Read

Feb 6 (Reuters) - Zealand Pharma A/S

* Patient recruitment completed for Phase II trial with glepaglutide for treatment of short bowel syndrome

* Zealand Pharma A/S says results of Phase II trial are expected mid 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below